Comorbidity as an Independent Risk Factor in Patients With Cancer: An 8-Year Population-Based Study

被引:15
作者
Chen, Chang-I [1 ]
Kuan, Ching-Feng [2 ]
Miser, James [3 ]
Fang, Yu-Ann [3 ]
Lam, Carlos [3 ]
Chiu, Wen-Ta [3 ]
Li, Yu-Chuan [3 ]
机构
[1] Taipei Med Univ, Coll Med, Taipei 110, Taipei, Taiwan
[2] Univ Sci & Technol, Taichung, Taiwan
[3] Taipei Med Univ, Taipei 110, Taipei, Taiwan
关键词
cancer with comorbidity; risk factor; population study; QUALITY-OF-LIFE; CARE; GUIDELINES; PATTERNS; MODELS; AGE;
D O I
10.1177/1010539513481491
中图分类号
R1 [预防医学、卫生学];
学科分类号
100235 [预防医学];
摘要
This study determined the prevalence of medical conditions in patients with cancer and their impact on outcome. We evaluated a cohort of 37 411 patients diagnosed with cancer between 2000 and 2008 in Taiwan, collecting the cancer diagnosis and chronic disease diagnoses. The severity of the comorbid condition was correlated with the cancer diagnosis and outcome. Overall, 71.9% of the study population had 1 or more comorbid conditions. Patients with none (n = 10 508), 1 (n = 8881), 2 (n = 6583), and 3 or more (n = 11 439) comorbid conditions had mortality rates of 11.49%, 15.99%, 19.61%, and 29.39%, respectively. Older patients with comorbid conditions had a significantly higher chance of death. Dementia, heart disease, or cerebrovascular diseases were associated with the highest mortality. Cancer patients with comorbid conditions have a significantly higher risk of death. Prevention and better medical management of comorbid conditions is likely to result in improved outcomes for patients with cancer.
引用
收藏
页码:NP590 / NP599
页数:10
相关论文
共 29 条
[1]
[Anonymous], 2013, SEER Cancer Statistics Review, 1975-2010
[2]
[Anonymous], 2005, CANC PATIENT CANC SU
[3]
AZIZ N, 2006, AM J NURS, V106, P3
[4]
Familial aggregation of diabetes and hypertension in a case-control study of colorectal neoplasia [J].
Brauer, PM ;
McKeown-Eyssen, GE ;
Jazmaji, V ;
Logan, AG ;
Andrews, DF ;
Jenkins, D ;
Marcon, N ;
Saibil, F ;
Cohen, L ;
Stern, H ;
Baron, D ;
Greenberg, G ;
Diamandis, E ;
Kakis, G ;
Singer, W ;
Steiner, G .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (08) :702-713
[5]
A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[6]
How to measure comorbidity: a critical review of available methods [J].
de Groot, V ;
Beckerman, H ;
Lankhorst, GJ ;
Bouter, LM .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (03) :221-229
[7]
DeLeve L.D., 2007, Drug-induced liver disease, P651
[8]
ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[9]
Regression models for relative survival [J].
Dickman, PW ;
Sloggett, A ;
Hills, M ;
Hakulinen, T .
STATISTICS IN MEDICINE, 2004, 23 (01) :51-64
[10]
Comorbidity measures for use with administrative data [J].
Elixhauser, A ;
Steiner, C ;
Harris, DR ;
Coffey, RN .
MEDICAL CARE, 1998, 36 (01) :8-27